| Maryland Wellness Llc | |
|
4128 Hayward Ave # W Baltimore MD 21215-4340 | |
| (410) 994-6491 | |
| Not Available |
| Full Name | Maryland Wellness Llc |
|---|---|
| Speciality | Clinic/Center |
| Location | 4128 Hayward Ave # W, Baltimore, Maryland |
| Authorized Official Name and Position | Casey Wu (DIRECTOR) |
| Authorized Official Contact | 2146591503 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Maryland Wellness Llc 4128 Hayward Ave # W Baltimore MD 21215-4340 Ph: (410) 994-6491 | Maryland Wellness Llc 4128 Hayward Ave # W Baltimore MD 21215-4340 Ph: (410) 994-6491 |
| NPI Number | 1003479668 |
|---|---|
| Provider Enumeration Date | 04/19/2019 |
| Last Update Date | 03/07/2023 |
| Certification Date | 03/07/2023 |
| Medicare PECOS PAC ID | 6406278803 |
|---|---|
| Medicare Enrollment ID | O20200611002298 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003479668 | NPI | - | NPPES |
| 220412460 | Other | MD | MARYLAND BEHAVIORAL HEALTH ADMINISTRATION |
| 220412463 | Other | MD | MARYLAND BEHAVIORAL HEALTH ADMINISTRATION |
| 220412462 | Other | MD | MARYLAND BEHAVIORAL HEALTH ADMINISTRATION |
| 907713800 | Medicaid | MD | |
| 220412461 | Other | MD | MARYLAND BEHAVIORAL HEALTH ADMINISTRATION |
| 220412464 | Other | MD | MARYLAND BEHAVIORAL HEALTH ADMINISTRATION |
| Provider Name | Ashlee Joyce Crawford |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1083210447 PECOS PAC ID: 9436559416 Enrollment ID: I20210614000129 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
| Provider Name | Rachel Oben |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194305771 PECOS PAC ID: 0941603955 Enrollment ID: I20210728003845 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
| Provider Name | Patrice Munford |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1881292993 PECOS PAC ID: 2961806526 Enrollment ID: I20210804003483 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
| Provider Name | Laurence Joseph Greenwood |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1386675601 PECOS PAC ID: 6901886217 Enrollment ID: I20210804003843 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
| Provider Name | Amani M Ahmed |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1063682995 PECOS PAC ID: 8224214747 Enrollment ID: I20210805003681 |
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
News Archive
While most hospitals have polices in place to prevent health care-associated infections, clinicians often fail to follow evidence-based guidelines established to prevent these infections, according to new research from Columbia University School of Nursing published in the American Journal of Infection Control.
Bayer HealthCare Pharmaceuticals Inc. announced today that its investigational compound regorafenib (BAY 73-4506) has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease has progressed despite at least imatinib and sunitinib as prior treatments.
The U.S. Attorney's Office announced today that 36 individuals face various federal prescription pill charges as part of the largest drug sweep operation in Kentucky's history.
A randomized double blind trial reported in the open access publication, Nutrition Journal, would suggest the answer is yes.
› Verified 7 days ago
Trinity Healthcare Services Incorporated Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4701 Belair Rd, Baltimore, MD 21206 Phone: 410-325-1850 | |
Michael B. Freedman Phd Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 6006 Park Heights Ave, Baltimore, MD 21215 Phone: 410-790-8433 Fax: 443-501-3379 | |
Sankofa Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 801 Key Hwy, Unit 442, Baltimore, MD 21230 Phone: 301-758-3682 | |
Home Free Iop Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 10 W Madison St Ste 11, Baltimore, MD 21201 Phone: 443-438-5239 | |
All Walks Of Life, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 E 25th St, Baltimore, MD 21218 Phone: 410-558-0019 | |
Devaughn Intervention Teach And Treat Options Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 4804 York Rd Ste 2, Baltimore, MD 21212 Phone: 443-873-8958 Fax: 443-873-8959 | |
Darryl M Coleman Md Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 115 N Monroe St, Baltimore, MD 21223 Phone: 443-708-4391 Fax: 443-708-4436 |